---
title: "Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292829202.md"
description: "Daiwa analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H with a HK$25.50 price target, while shares closed at HK$23.60. The stock holds a Strong Buy consensus with an average price target of €3.24. Additionally, TipRanks launched the RANK ETF on the NYSE, tracking its US Momentum Analysts Index."
datetime: "2026-07-16T00:26:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292829202.md)
  - [en](https://longbridge.com/en/news/292829202.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292829202.md)
generator: "portal-rs"
---

# Daiwa Remains a Buy on Pharmaron Beijing Co., Ltd. Class H (17Q1)

Daiwa analyst maintained a Buy rating on Pharmaron Beijing Co., Ltd. Class H on July 14 and set a price target of HK$25.50. The company’s shares closed last Tuesday at HK$23.60.

### TipRanks Welcomes a New ETF – NYSE:RANK

-   TipRanks has entered a new arena in the investing world, powering the index of an ETF based on its unique data now trading under the ticker RANK on the NYSE.
-   RANK tracks the performance of the TipRanks US Momentum Analysts Index, a rules-based index of 50 large U.S. companies.

Pharmaron Beijing Co., Ltd. Class H has an analyst consensus of Strong Buy, with a price target consensus of €3.24.

### Related Stocks

- [300759.CN](https://longbridge.com/en/quote/300759.CN.md)
- [03759.HK](https://longbridge.com/en/quote/03759.HK.md)
- [RANK.US](https://longbridge.com/en/quote/RANK.US.md)
- [8601.JP](https://longbridge.com/en/quote/8601.JP.md)

## Related News & Research

- [G Sachs: China CRO/CDMO Industry Recovery Pace Clear; Positive on WUXI Series, PHARMARON, ASYMCHEM, TIGERMED and GENSCRIPT BIO](https://longbridge.com/en/news/298712241.md)
- [Roth MKM Reaffirms Their Buy Rating on Trulite (TRUL)](https://longbridge.com/en/news/293045966.md)
- [Intermonte Reaffirms Their Buy Rating on Unidata S.P.A. (UD)](https://longbridge.com/en/news/298745257.md)
- [UBS Sticks to Its Buy Rating for Inditex (0QWI)](https://longbridge.com/en/news/298557093.md)
- [Lovesac: Buy Rating Reaffirmed as Solid Balance Sheet and Compelling Valuation Support $26 TipRanks Price Target Despite Near-Term Headwinds](https://longbridge.com/en/news/298807790.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**